Healthcare

This bill adds hepatitis C antibody (anti-HCV) testing to the standard blood screening required for all pregnant women in Tennessee during initial prenatal visits and between weeks 28-32 of pregnancy. If the anti-HCV test is reactive, labs must automatically conduct a follow-up HCV RNA test without requiring additional orders. It directly affects all pregnant women receiving routine prenatal care in Tennessee, expanding the required screening panel to include hepatitis C alongside existing tests for syphilis, rubella, and hepatitis B. The changes take effect July 1, 2025, and align hepatitis C testing protocols with existing disease reporting requirements for maternal health.

HB 404 extends the professional music therapy advisory committee under Tennessee's psychology board until June 30, 2027. This bill updates Tennessee Code Sections 4-29-246 and 4-29-248 to formally maintain the committee's existence, preventing its automatic termination. The committee, which advises the Board of Examiners in Psychology on music therapy licensure, is directly affected by this extension. The change ensures continuity for this advisory body without altering any substantive licensing rules.

HB 15 would allow Tennessee's governor to expand Medicaid eligibility exclusively for sickle cell disease treatment, in alignment with federal law. The bill requires the governor to negotiate with federal health officials (Centers for Medicare and Medicaid Services) on the specific terms of this expansion. This change would directly affect Tennessee residents diagnosed with sickle cell disease by potentially providing Medicaid coverage for their treatment. The expansion is strictly limited to sickle cell disease and must comply with the federal Patient Protection and Affordable Care Act.

HB 18 proposes a temporary health coverage program for Tennesseans who don't qualify for existing TennCare or CoverKids. It would provide up to 60 months of medical assistance (resetting at age 21) to individuals under 21 with income ≤138% of the federal poverty level, or adults ≥21 with similar income, subject to strict 12-month/24-month usage limits. The program requires a federal waiver by December 2025, uses 90% federal/10% state funding, and explicitly states it does not replace eligibility for regular programs (benefits pause if enrollment becomes possible). The bill failed in the Insurance Committee on March 5, 2025, and remains inactive.

SB 610 requires TennCare to cover continuous glucose monitors (CGMs) for eligible members with specific diabetes conditions. It directly affects TennCare enrollees diagnosed with Type 1 diabetes, gestational diabetes, or Type 2 diabetes meeting documented criteria like frequent low blood sugar episodes, high A1C levels, or hospitalizations related to diabetes complications. The bill mandates coverage only when prescribed by an endocrinologist or diabetes specialist confirming the member meets the eligibility requirements. The law takes effect January 1, 2026.